Literature DB >> 4587032

Proceedings: Clinical evaluation of perhexiline maleate in the treatment of chronic cardiac arrhythmias of patients with coronary heart disease.

M Sukerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4587032

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  2 in total

1.  Inhibition of HERG channels stably expressed in a mammalian cell line by the antianginal agent perhexiline maleate.

Authors:  B D Walker; S M Valenzuela; C B Singleton; H Tie; J A Bursill; K R Wyse; M R Qiu; S N Breit; T J Campbell
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.

Authors:  R R Shah; N S Oates; J R Idle; R L Smith; J D Lockhart
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.